Comparison between adherence assessments and blood glucose monitoring measures to predict glycemic control in adults with type 1 diabetes: a cross-sectional study by Gabriela Heiden Telo et al.




assessments and blood glucose monitoring 
measures to predict glycemic control in adults 
with type 1 diabetes: a cross-sectional study
Gabriela Heiden Telo1*, Martina Schaan de Souza1, Thais Stürmer Andrade1 and Beatriz D’Agord Schaan1,2
Abstract 
Background: Adherence to treatment has been defined as the degree to which a patient’s behavior corresponds to 
medical or health advice; however, the most appropriate method to evaluate adherence to diabetes care has yet to 
be identified. We conducted analyses to compare adherence assessments and blood glucose monitoring measures 
with regard to their ability to predict glycemic control in adults with type 1 diabetes.
Methods: We analyzed four instruments to evaluate adherence: Self-Care Inventory-Revised, a self-administered sur-
vey; Diabetes Self-Monitoring Profile (DSMP), administered by trained researchers; a categorical (yes/no/sometimes) 
adherence self-evaluation; and a continuous (0–100) adherence self-evaluation. Blood glucose monitoring frequency 
was evaluated by self-report, diary, and meter download.
Results: Participants (n = 82) were aged 39.0 ± 13.1 years with a mean diabetes duration of 21.2 ± 11.1 years; 27 % 
monitored blood glucose >4 times/day. The DSMP score was the strongest predictor of glycemic control (r = −0.32, 
P = 0.004) among adherence assessments, while blood glucose monitoring frequency assessed by meter down-
load was the strongest predictor among blood glucose monitoring measures (r = −40, P < 0.001). All the self-report 
assessments had a significant but weak correlation with glycemic control (r ≤ 0.28, P ≤ 0.02). The final adjusted model 
identified the assessment of blood glucose monitoring frequency by meter download as the most robust predictor of 
HbA1c (estimate effect size = −0.58, P = 0.003).
Conclusions: In efforts to evaluate adherence, blood glucose monitoring frequency assessed by meter download 
has the strongest relationship with glycemic control in adults with type 1 diabetes.
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Background
Adherence to treatment has been defined as the degree 
to which a patient’s behavior corresponds to medical or 
health advice [1]. Despite all evidence that achieving good 
glycemic control helps prevent microvascular and macro-
vascular complications of diabetes, many patients do not 
achieve such control, mostly because treatment adherence 
is poor [2, 3]. Sustained glycemic control has been shown 
to be difficult in adults of all ages, as the management 
of diabetes places substantial demands on patients [4]. 
Challenges to adherence and active patient engagement 
in diabetes care include, but are not limited to, physical 
and emotional barriers, complex treatment regimens, and 
financial burdens [5]. There is a tendency in the literature 
to treat adherence and glycemic control as interchange-
able constructs [6], while, in fact, patient adherence and 
metabolic control need to be assessed both independently 
and concomitantly [6, 7]. Patients in good glycemic con-
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In the literature and in clinical practice, there are vari-
ous methods of assessing adherence to diabetes care, 
such as structured interviews, self-report, diaries, and 
electronic monitoring [8]. Many of these methods have 
been shown to correlate well with glycemic control; 
however, some traditional methods, such as insulin bot-
tles count at the pharmacy, may not be suitable enough 
as an adherence measure in type 1 diabetes consider-
ing that many patients should change their daily insulin 
dose based on sliding scales and carb counting, which 
may interfere in adherence interpretation [9]. On the 
other hand, surveys have been validated and widely 
used as measures to evaluate adherence in this popula-
tion [10, 11]. Their domains usually capture behavioral 
characteristics related to diabetes management, such as 
insulin administration, meal plans, frequency/intensity 
of exercises, frequency of blood glucose monitoring, and 
hypoglycemia [6]. The appropriate execution of all these 
tasks was shown to promote optimal glycemic control [2, 
3], which solidified the association between adherence 
and metabolic results in diabetes treatment. In contrast, 
several studies have demonstrated the importance of 
focusing on specific adherence behaviors, such as blood 
glucose monitoring [12, 13]. These studies demonstrated 
strong association between a higher frequency of blood 
glucose monitoring and lower hemoglobin A1c (HbA1c) 
levels. However, the most appropriate method to evaluate 
adherence to diabetes care in adults with type 1 diabetes 
has yet to be identified.
In this study, we sought to investigate different meth-
ods of assessing adherence and glycemic control. To 
accurately predict HbA1c in adults with type 1 diabetes, 
we designed a cross-sectional study to evaluate and com-
pare adherence assessments by structured surveys and 
self-report, as well as blood glucose monitoring measures 
by self-report, diary, and electronic devices. Such knowl-
edge may enhance opportunities to better understand 
this important barrier and assist in development of strat-
egies to improve adherence to diabetes care and glycemic 
control in patients with type 1 diabetes.
Research design and methods
Participants
We conducted exploratory multivariable analyses to 
compare adherence assessments and blood glucose 
monitoring measures with regard to their ability to 
predict HbA1c in adults with type 1 diabetes on injec-
tion therapy. All participants included in these analyses 
met the following inclusion criteria: ≥18  years of age 
and type 1 diabetes duration ≥1 year. Exclusion criteria 
included a developmental disability or a psychiatric dis-
order that would interfere with reliable completion of the 
structured instruments. We selected patients from the 
outpatient electronic medical record database of a single 
tertiary public hospital in Southern Brazil. The Institu-
tional Review Board approved the study protocols, and 
all participants signed informed consent forms prior to 
beginning any study procedure.
Measures
Adherence assessments
We analyzed four different instruments to evaluate 
adherence to diabetes management. First, participants 
were asked to respond to a three-level (no/sometimes/
yes) categorical self-report question (“In the past month, 
did you take care of your diabetes as your doctor rec-
ommended?”). Patients were also asked to characterize 
themselves according to their adherence to diabetes care 
on a continuous self-evaluation scale, ranging from 0 to 
100. Additionally, all participants completed the two fol-
lowing previously validated adherence surveys:
  • Self-Care Inventory-Revised version (SCI-R) [11, 14]: 
the 14-item SCI-R [14] is a self-administered survey, 
which measures adherence to different diabetes man-
agement tasks on a 5-point Likert scale. Responses 
range from 1 = never to 5 = always, and scores range 
from 14 to 70. Higher scores indicate greater adher-
ence to type 1 diabetes treatment.
  • Diabetes Self-Monitoring Profile (DSMP) [10, 14]: 
the DSMP [14] is a 24-item survey administered by 
trained researchers, which measures adherence to 
5 different domains: exercises, hypoglycemia, diet, 
blood glucose tests, and insulin dose. Scores range 
from 0 to 96. Higher scores indicate greater adher-
ence to type 1 diabetes treatment.
Blood glucose monitoring measures
We evaluated blood glucose monitoring frequency by 
three different ways: self-report, diary, and meter down-
load. Participants were asked to take their blood glucose 
meters and blood glucose diary to the study visit. An 
average frequency of blood glucose monitoring per day 
was calculated for the last 14 days, not including the visit 
day.
After collecting responses to the adherence assess-
ments and blood glucose monitoring data, trained 
researchers interviewed participants to obtain additional 
clinical and demographic data. Socioeconomic status 
was characterized based on the Associação Brasileira de 
Empresas de Pesquisa criteria [15], which includes data 
regarding costumer goods and parental education. Gly-
cemic control was assessed by HbA1c, which was per-
formed in a clinical laboratory using a Diabetes Control 
and Complications Trial standardized assay (high-perfor-
mance liquid chromatography, ref. range 4.0–6.0 %).
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Data analysis
Analyses were performed using SAS software (version 
9.3; Institute, Inc., Cary, NC, USA). Descriptive data 
are presented as mean  ±  standard deviation (SD) or 
percentage. Statistical analyses included Pearson cor-
relations to determine associations between adherence 
assessments and blood glucose monitoring measures. 
Exploratory multivariable analyses were conducted 
using stepwise regression to identify, among all adher-
ence assessments and blood glucose monitoring meas-
ures, the best predictor of HbA1c. Three different steps 
were performed in the stepwise analyses: first, all three 
blood glucose monitoring assessments were included 
in the HbA1c model; second, all four adherence assess-
ments were included in the HbA1c model; and, finally, 
after selecting the best HbA1c predictors among the 
adherence assessments and blood glucose monitoring 
measures based on the two first steps, a final step evalu-
ated the two selected measures in order to elucidate 
which one could better predict HbA1c. Generalized lin-
ear model was then performed, including mean HbA1c 
as the dependent variable and the best adherence meas-
ure based on the final exploratory step as the independ-
ent variable. Multivariable analyses were performed to 
evaluate the impact of demographics and clinical charac-
teristics on the adherence-glycemic control relationship. 
Also, as insulin regimen may interfere with adherence to 
diabetes treatment, multivariable analyses included this 
variable to evaluate its impact on the results. An alpha 
level of <0.05 was used to determine statistical signifi-
cance. The Cohen’s index was used to determine correla-
tion coefficients and effect size [16]. A sample size of 82 
was calculated as sufficient to detect a moderate effect 
size between HbA1c and adherence measures consider-
ing an alpha of 0.05 and power of 80 %.
Results
Participant characteristics
In total, 103 eligible patients were approached to partici-
pate in this study (from March 2014 to September 2014), 
of those 82 (80 %) agreed to participate. All participants 
provided written informed consent. Those who declined 
participation had similar age, diabetes duration, and 
HbA1c as those who agreed to participate (P > 0.05). All 
participants provided data regarding blood glucose meter 
and diary and responded to the study visit interview and 
surveys. Participants had a mean age of 39.0 ± 13.1 years 
and mean diabetes duration of 21.2 ±  11.1  years; 39  % 
were overweight/obese, 27  % had a frequency of blood 
glucose monitoring >4 times/day according to the study 
visit interview (see Table 1), and 82 % were under flexible 
insulin regimens, such as sliding scale and carb counting. 
All participants in this study were using daily multiple 
injections for diabetes treatment and only 11 % met the 
ADA HbA1c target of <7 % [17].
Measures results
All adherence assessments appeared to be interrelated 
(P  <  0.01), as did the blood glucose monitoring meas-
ures (P  <  0.001). The correlations between DSMP score 
and blood glucose monitoring frequency assessed by 
self-report (r  =  0.69, P  <  0.001) and meter download 
(r = 0.52, P < 0.001) were identified as the two strongest 
correlations between the adherence and blood glucose 
monitoring measures (see Table 2).
Exploratory analyses using stepwise multivariable 
regression were conducted to identify the best predic-
tor of HbA1c based on all the adherence and blood glu-
cose monitoring measures. In the first step, among all the 
blood glucose monitoring measures, frequency of blood 
glucose monitoring assessed by meter download was 
the strongest predictor of HbA1c (r  =  −40, P  <  0.001) 
(see Table 3a). In the second step, among all the adher-
ence assessments, DSMP score was the strongest pre-
dictor of glycemic control (r  =  −0.32, P  =  0.004) (see 
Table  3b). During the two first steps, all adherence and 
blood glucose assessments were significantly correlated 
with HbA1c (P  <  0.05), except for frequency of blood 
glucose monitoring by diary (r = −0.20, P =  0.07). All 
self-report assessments, which included the blood glu-
cose monitoring frequency self-report, categorical adher-
ence self-evaluation question, and continuous adherence 
self-evaluation question, had a weak, although signifi-
cant, correlation with glycemic control. In the final step, 
which included the best adherence and blood glucose 
Table 1 Demographic and  clinical characteristics of  study 
participants
Data are mean ± SD or n (%)
N = 82
Age (years) 39.0 ± 13.1
Sex (% male) 63





 Very low 2
Diabetes duration (years) 21.2 ± 11.1
Blood glucose monitoring (% ≥4 times/day) 27
HbA1c (%) 8.9 ± 2.2
HbA1c (mmol/mol) 74 ± 24
Daily insulin dose (units/kg) 0.74 ± 0.30
Weight status (% overweight/obese) 39
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monitoring assessments based on the two first steps, fre-
quency of blood glucose monitoring by meter download 
emerged as the most robust predictor of glycemic control 
(r = −33, P < 0.001). The DSMP score, in this final model, 
was no longer significant (r = −15, P = 0.22).
Generalized linear model was initially performed to 
evaluate the interaction between HbA1c and blood glu-
cose monitoring frequency assessed by meter download. 
This analysis showed that as frequency of blood glucose 
monitoring increased 1 time/day, HbA1c decreased 
0.63 % (P < 0.001). The final adjusted model (P < 0.001), 
which controlled for age, diabetes duration, insulin dose, 
insulin regimen, and socioeconomic status, slightly 
decreased the adherence-glycemic control association 
(estimate effect  =  −0.59, P  =  0.003). Demographics 
and clinical characteristics were not significant in this 
model (P  >  0.05). As DSMP may also be an alternative 
while assessing adherence in clinical settings, we also 
performed univariate analysis to evaluate the interaction 
between HbA1c and DSMP scores. In this analysis, as 
DSMP score increased by 10 points, HbA1c decreased by 
0.74 % (P = 0.004).
Discussion
The conceptual and methodological issues related to 
adherence assessments are important for research but 
also have widespread clinical application. How health-
care providers conceptualize adherence impacts diabetes 
management recommendations [6]. In order to better 
understand the different instruments available to assess 
adherence in adults with type 1 diabetes, we sought to 
evaluate and compare adherence assessments and blood 
Table 2 Correlation between adherence and blood glucose monitoring assessments
SCI-R Self Care Inventory-Revised, DSMP Diabetes Self-Monitoring Profile
Assessments Blood glucose monitoring  
frequency (self-report) (r)
Blood glucose monitoring  
frequency (diary) (r)
Blood glucose monitoring 
frequency (meter collection/
downloading) (r)
Self-administered survey (SCI-R) 0.50 0.46 0.40
P value <0.0001 <0.0001 0.0002
Structured interview/survey (DSMP) 0.69 0.32 0.52
P value <0.0001 0.004 <0.0001
Self-report (categorical) 0.31 0.28 0.41
P value 0.005 0.01 0.0001
Self-report (continuous) 0.34 0.25 0.33
P value 0.002 0.02 0.003
Table 3 Stepwise regression for HbA1c and adherence assessments
Italic values indicate variables selected by the stepwise regression
SCI-R Self Care Inventory-Revised, DSMP Diabetes Self-Monitoring Profile, β standardized estimate
Assessments R2 P value β
(a) Blood glucose monitoring assessments
 Blood glucose monitoring frequency (self-report) 0.08 0.01 −0.28
 Blood glucose monitoring frequency (diary) 0.04 0.07 −0.20
 Blood glucose monitoring frequency (meter collection/downloading) 0.16 0.0002 −0.40
Blood glucose monitoring frequency (meter collection/downloading) 0.16 0.0002 −0.40
(b) Adherence-specific assessments
 Self-report (categorical) 0.06 0.02 −0.27
 Self-report (continuous) 0.07 0.01 −0.27
 Self-administered survey (SCI-R) 0.05 0.04 −0.23
 Structured interview/survey (DSMP) 0.10 0.004 −0.32
Structured interview/survey (DSMP) 0.10 0.004 −0.32
(c) Final model 0.18
 Structured interview/survey (DSMP) 0.22 −0.15
 Blood glucose meter collection/downloading 0.007 −0.33
Blood glucose meter collection/downloading 0.16 0.0002 −0.40
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glucose monitoring measures to predict glycemic control. 
In this study, among the four instruments to assess adher-
ence (DSMP, SCI-R, and categorical and continuous self-
evaluations), DSMP score was the strongest predictor of 
glycemic control, while blood glucose monitoring fre-
quency assessed by meter download was the most robust 
predictor of HbA1c among the blood glucose monitoring 
measures and all the studied assessments.
Our findings highlight the observation that there is 
a strong association between frequency of blood glu-
cose monitoring and glycemic control in a population of 
patients with type 1 diabetes. Indeed, the T1D Exchange 
Clinic Network [13] clearly demonstrated that for all 
ages, increased frequency of blood glucose monitoring 
is associated with lower HbA1c. Previous studies also 
identified that capillary glucose information was valuable 
for making appropriate decisions with regard to insulin 
doses [18]. This is true even after adjusting for demo-
graphics and socioeconomic confounders [13]. In this 
study, demographics and diabetes clinical characteristics 
did not appear to have an impact on the adherence-gly-
cemic control relationship, although it is true that some 
methods used to evaluate demographics such as socio-
economic status may not be enough accurate and may 
underestimate its impact on the results [15]. Also, we 
know that frequent blood glucose monitoring by itself 
does not directly impact HbA1c; the capillary blood glu-
cose information must be used effectively in diabetes 
management in order for the frequency of monitoring to 
impact glycemic control [5, 19]. Thus, frequency of blood 
glucose monitoring seems to be a behavior strongly rep-
resentative of adherence and very well associated with 
glycemic control.
Besides frequency of blood glucose monitoring, many 
other domains seem to be related to adherence and 
have been assessed by different surveys [10, 11]. How-
ever, despite the well-known importance of adherence in 
achieving good glycemic control and preventing diabetes 
complications [3, 20], there are a few questionnaires with 
established psychometric properties to assess it [10, 11, 
21, 22]. In this study, we evaluated the two instruments 
validated in Brazilian Portuguese to assess adherence in 
patients with type 1 diabetes [14]. Both surveys, as well 
as the self-evaluation questions, demonstrated significant 
correlation with glycemic control and seem to be appro-
priate to evaluate adherence in adults with type 1 diabe-
tes. The DSMP, which includes domains regarding diet, 
exercises, insulin, blood glucose monitoring frequency, 
and hypoglycemia, showed to have the most power-
ful questions to predict glycemic control when com-
pared to self-evaluations. However, it is essential to state 
that, although surveys are an easy-to-use instrument to 
assess adherence, blood glucose measures assessed by 
meter download appear to have the strongest relation-
ship with HbA1c in adults with type 1 diabetes. Surveys 
may have utility for periodic use with patients in clinical 
and research settings [9]; however, although surveys can 
predict glycemic control and health outcomes, they can-
not be interpreted as substitutes of HbA1c and must be 
analyzed with consideration of the clinical setting. Inter-
estingly, in this study, all the self-report assessments, 
including the SCI-R, had a significant but weak corre-
lation with glycemic control. Consistent with previous 
studies [6, 13], adherence assessments by self-evaluation 
may over-report engagement in diabetes tasks and fre-
quency of blood glucose self-monitoring.
It is important that we do not overestimate our find-
ings. This study involved a cross-sectional design, and 
our results represent associations, not direct causal 
relationships, between glycemic control and adherence 
measures. Moreover, as occurs frequently in behavioral 
studies, we were reliant on self-reports that were not con-
firmed objectively. Further studies may want to confirm 
our findings in longitudinal research designs, while con-
trolling for the timeframe of assessing adherence behav-
iors. Moreover, future studies need to be designed to 
better evaluate the impact of demographic characteristics 
on adherence in order to best predict glycemic control.
Conclusions
To our knowledge, this is the first study designed to com-
pare different methods to assess adherence and blood 
glucose monitoring frequency in adults with type 1 dia-
betes. Our findings highlight blood glucose monitor-
ing frequency by meter download as the best method to 
assess adherence and glycemic control. The knowledge 
from this study stresses the importance of downloading 
blood glucose monitoring devices and provides opportu-
nities to better understand and assess adherence to dia-
betes management. Appropriately identifying modifiable 
characteristics associated with glycemic control may aid 
providers as they consider a diabetes prescription or man-
agement plan. Further studies are necessary to determine 
the role of each adherence assessment in diabetes care 
longitudinally.
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